Target intelligence / Profile preview

Antigen-specific CD4-positive T cell (CD4+ T cell) (CD4+ T cell)

Target
CD4+ T cell
Molecular classification
Other (Cellular Target), Receptor (T-cell receptor complex)
01

Overview

Antigen-specific CD4-positive T cells, commonly known as helper T cells, are a fundamental subset of lymphocytes essential for the coordination of the adaptive immune response (Janeway et al., 2017). These cells are characterized by the expression of the CD4 co-receptor, which enables them to recognize specific peptide antigens presented by Major Histocompatibility Complex class II (MHC II) molecules on professional antigen-presenting cells (StatPearls, 2024). Upon encountering their cognate antigen, these cells undergo clonal expansion and differentiate into various functional subsets, such as Th1, Th2, Th17, and regulatory T cells (Tregs), each defined by a unique cytokine profile that directs the activity of B cells, CD8+ T cells, and innate immune cells (NIH, 2023). In clinical contexts, these cells are primary targets for immunomodulation; for instance, they are suppressed in organ transplantation and autoimmune diseases to prevent tissue damage, while in oncology and vaccinology, strategies aim to enhance their activation to mount effective anti-tumor or anti-pathogen responses (PubMed, 2022). Dysregulation of antigen-specific CD4+ T cells is a hallmark of numerous conditions, including rheumatoid arthritis, multiple sclerosis, and HIV/AIDS, where the loss of these cells leads to profound immunodeficiency (Nature Reviews Immunology, 2021).

Other names
Helper T cellsTh cellsCD4+ T lymphocytesAntigen-specific helper T cells
02

Mechanism of action

Modulation of T-cell receptor signaling, inhibition of costimulatory pathways (e.g., CD80/86 blockade), calcineurin inhibition, and immune checkpoint blockade (PD-1/CTLA-4).

03

Biological functions

Immune responseCell proliferationCytokine productionB cell helpImmunological memory
04

Disease associations

InfectionCancerAutoimmune diseaseInflammationAllergyGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)Immune effector cell-associated neurotoxicity syndrome (ICANS)Increased risk of opportunistic infectionsAutoimmune-related adverse events (irAEs)
06

Interacting drugs

Abatacept

7 more in the full profile.

07

Biomarkers

MHC class II tetramersCD154 (CD40L) expressionInterferon-gamma (IFN-γ)Interleukin-2 (IL-2)CD25FoxP3

Beyond the preview

Go deeper on Antigen-specific CD4-positive T cell (CD4+ T cell) (CD4+ T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-specific CD4-positive T cell (CD4+ T cell) (CD4+ T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call